Context Therapeutics Inc. (CNTX) vs Seres Therapeutics, Inc. (MCRB)
A side-by-side comparison of Context Therapeutics Inc. and Seres Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CNTX
Context Therapeutics Inc.
$0.33HealthcareDelayed quote: Oct 6, 2026, 12:15 PM EDT
MCRB
Seres Therapeutics, Inc.
$2.88HealthcareDelayed quote: Oct 6, 2026, 12:14 PM EDT
Total return — CNTX vs MCRB
growth of $100 · dividends reinvested · last 5yCNTX -93.4% (-41.9%/yr)MCRB -97.8% (-53.2%/yr)CNTX compounded faster over this window
CNTX MCRB
CNTX vs MCRB: by the numbers
- •CNTX is the larger company ($31M vs $28M market cap).
- •Both run net losses; CNTX's is the smaller (0.00% vs -1192.94% net margin).
Metrics side by side
Valuation
| Metric | CNTX | MCRB |
|---|---|---|
| P/S ratio | N/A | 14.81 |
| P/B ratio | 0.80 | 0.81 |
Profitability
| Metric | CNTX | MCRB |
|---|---|---|
| Gross margin | 0.00% | -423.83% |
| Operating margin | 0.00% | -11910.14% |
| Net margin | 0.00% | -1192.94% |
| ROE | -120.40% | -65.05% |
| ROIC | -126.84% | -103.04% |
Growth (annualized)
| Metric | CNTX | MCRB |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -42.51% |
| Total return CAGR (5Y) | N/A | -53.37% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.